Post-operative Urinary Retention (POUR) Following Thoracic Surgery

Who is this study for? Males?65 years old with planned surgical procedure of a video assisted thoracoscopic surgery
What treatments are being studied? Tamsulosin
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY

Inability to urinate a common complication that happens to many patients after a surgery, especially in men over 60 years of age who undergo surgery on their chest. Urinary retention is uncomfortable, increases anxiety, increases hospital length of stay, and leads to more procedures such as putting in a bladder catheter (Foley). This is uncomfortable, and can lead to bleeding, infection, damage to the urethra and/or bladder and bladder spasm. The goal of this study is to attempt to prevent inability to urinate by giving patients a medication called Flomax (Tamusolin) every day beginning a week before surgery. That medication relaxes the prostate. It's approved by the Food and Drug Administration (FDA) to improve urinary flow in those with enlarged prostates. It is also commonly used in patients with bladder problems due to inability to urinate who have required a Foley.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 50
Healthy Volunteers: t
View:

• Males

• ≥50 years old Planned surgical procedure of a minimally invasive thoracic surgical procedure (wedge resection, segmentectomy, lobectomy, pleural biopsy, or pleurodesis) Surgery scheduled more than 3 days from the time of consent

Locations
United States
New Jersey
Daniel Mansour
RECRUITING
Hackensack
Contact Information
Primary
Daniel Mansour, MD
daniel.mansour@hmhn.org
551-996-2000
Time Frame
Start Date: 2018-05-07
Estimated Completion Date: 2026-03-30
Participants
Target number of participants: 127
Treatments
Experimental: 1 week Pre-operative Tamsulosin administration
Experimental: 3 days Pre-operative Tamsulosin administration
Related Therapeutic Areas
Sponsors
Leads: Hackensack Meridian Health

This content was sourced from clinicaltrials.gov